Clinical trials: sponsored by Bristol-Myers Squibb

Esophageal Neoplasm

A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer

• Unknown status
• Age: 18 to 79 years
• Phase 2

This study is for patients with esophageal cancer that has spread to other areas. The purpose of this study is to: 1. Determine how well a combination of taxol, UFT, and leucovorin work in these patients, 2.

Trial name

NCT00037089

Testing

UFT (Tegafur/Uracil)

Where

United States

Sponsor

Edelman, Martin, M.D.